Industry Symposia

Join us at ASBrS 2026 for a gameshow-inspired symposium that turns learning into an experience! Meet our medical team, challenge yourself with interactive learning activities on the Oncotype DX Breast Recurrence Score® and Riskguard® tests, and enjoy a strolling dinner in the Emerald City.

Join us for a dinner symposium as we examine the breast surgeon’s role in initiating tumor-informed molecular residual disease (MRD) testing at diagnosis. Through focused patient cases, the faculty panel will discuss how detecting circulating tumor DNA establishes a personalized molecular baseline, enables objective assessment of treatment response beyond pCR versus non-pCR, and supports systemic monitoring for recurrence beyond what breast imaging alone can provide.

Program Objective

Attendees will leave with a clear framework for integrating MRD into modern breast surgical practice and an understanding of how early surgical leadership elevates tumor board discussions and advances state-of-the-art, biology-driven breast cancer care.

For More Information

Jodi Hafemeister, Director of Marketing, Breast Oncology
Email: jhafemeister@natera.com ; Cell: 727‑512‑5072

Sleepless in Seattle: What's Keeping Surgeons Up at Night?

Join us at this year's ASBrS Annual Meeting as Dr. Susan K. Boolbol returns for Thursday Night Live with special guests, unfiltered conversation and a few exciting surprises along the way...

Join Mehran Habibi, MD, Chief of Breast Surgery at Baptist Health Miami Cancer Institute, as he presents real-world cases showing how MammaPrint® + BluePrint® genomic insights can change neoadjuvant planning and surgical decision-making in patients with early-stage breast cancer. Dr. Habibi will also highlight the latest neoadjuvant data and demonstrate how letting tumor biology lead can help surgeons personalize treatment and optimize outcomes.

For More Information

Karen Guzdzial at marketing@agendia.com

This symposium highlights breast cryoablation as a practical, minimally invasive option aligned with the shift toward de-escalated breast cancer care. Expert faculty will present supporting clinical data, share real-world insights on program implementation, and review best practices for post-ablation follow-up. The session is led by a multidisciplinary panel of breast surgeons and radiologists, with an emphasis on practical application and hands-on learning.

Program Objectives

Provide a comprehensive overview of breast cryoablation within the evolving framework of de-escalation of care, including a review of the clinical evidence supporting its safety and efficacy. Equip participants with practical strategies to implement and grow a cryoablation program, establish appropriate post-ablation follow-up protocols, and develop procedural competency through hands-on experience.

Speakers

• Dr. Richard Fine
• Dr. Lauren Kopicky
• Dr. Micheal Sabel
• Dr. Robert Ward

For More Information

Cynthia Justiniano, cynthiaj@icecure-medical.com, 954‑299‑6170

This scientific symposium, featuring leading breast cancer surgeons, will highlight the latest clinical data on breast-conserving surgery (BCS) combined with post-lumpectomy radiofrequency ablation (RFA) and its impact on reducing the need for adjuvant radiation therapy (RT).

Recent evidence demonstrates that intraoperative RFA applied to the lumpectomy cavity can create an additional circumferential tumor-free margin, significantly decreasing close or positive margins and lowering re-excision rates. Emerging long-term data also suggest that, in carefully selected patient populations, BCS + RFA may maintain local control while reducing—or potentially eliminating—the need for whole-breast radiation.

The symposium will review updated outcomes data, comparative analyses with other intraoperative technologies such as cryoablation and IORT, and real-world case studies utilizing a next-generation RFA probe specifically engineered for optimized energy delivery within the lumpectomy cavity.

Moderator: Sheldon Feldman, MD, FACS
Speaker: Suzanne Klimberg, MD, PhD, MSHCT, FACS, MAMSE

Join us for an immersive Breakfast Bioskills Symposium focused on Mastectomy Flat Closure techniques and Closed Incision Negative Pressure Therapy (ciNPT), featuring expert-led, hands-on cadaver training and real-world clinical insights. Cadaver lab participation is limited and available on a first-come, first-served basis.

Once cadaver lab capacity is reached, additional registrants will view the hands-on portion via live stream from an overflow room. All attendees will participate together during breakfast and the didactic session, after which cadaver lab participants will move to the lab while remaining attendees continue to watch live and engage in real time.

Speakers

• Abhishek Chatterjee, MD, MBA
  Chief, Division of Plastic Surgery
  Division of Surgical Oncology
  Tufts Medical Center
  Boston, MA
• Regina M. Fearmonti, MD
  Fearmonti Plastic Surgery
  Alon Aesthetics Plastic Surgery & Skin
  San Antonio, TX
• Nicholas Champion, MD
  Breast Oncology
  H. Lee Moffitt Cancer Center and Research Institute
  Tampa, FL

Join Myriad Oncology™ in examining the evolving role of tumor informed molecular residual disease (MRD) testing in the treatment of breast cancer. A multidisciplinary panel discussion will address current evidence, technical and practical considerations, and future directions for the incorporation of MRD testing into surgical and postoperative care pathways.

Join us for a dinner symposium on managing atypical hyperplasia patients using genomic test, BBDRisk Dx, for personalized clinical decision-making. The test is approved for coverage by Medicare, Medicare Advantage Plans, Medicaid of several States, UnitedHealthCare, Cigna, Anthem BCBS, Federal BCBS, BCBS of most States and several other commercial insurance agencies. The clinical study, test development, validation and publications will be presented. Data on several Case Reports will also be presented. Audience will have an opportunity to ask questions.

Topics to Be Discussed

• Breast Cancer Rates Among Atypical Hyperplasia Patients
• Genomic Test for Personalized Risk Assessment
• Genomic Information for Informed Management

Presenter

• Indira Poola, PhD
  Scientist, Silbiotech, Inc.,
  Former Professor of Biochemistry
  and Molecular Biology and Surgery

For More Information

Indira Poola, ipoola@silbiotech.com, 301‑787‑1216

Endoscopic nipple-sparing mastectomy (E-NSM) is shaping the future of minimally invasive breast surgery. Join our global panel of surgeons to discover why E-NSM is a growing part of their practice. The panel will share experiences from initial U.S. cases, procedural footage, the benefits of the technique, and insights from current clinical evidence. Come see how E-NSM is taking breast surgery to the next level!

Panelists

• Richard Ehlers, MD – Moderator
• John Davis, MD
• Paula Escobar, MD
• Robert Milligan, MD
• Giada Pozzi, MD

Join us at the ASBrS Annual Meeting on Saturday, May 2, 2026, for a breakfast symposium to learn about a novel approach to incorporate breast supine MRI imagery into breast cancer localization and surgical guidance. We will be discussing the Breast Cancer Locator, an innovative, patient-specific, 3D-printed guide, and the Visualizer™, an interactive 3D model designed to support surgical planning. 

Dr. Jennifer Gass, Chief of Surgery at Women & Infants Hospital, and Principal Investigator of the Breast Cancer Locator Study, together with fellow study investigators, will present an overview of the pivotal clinical data and share illustrative case examples. 

This symposium will bring together surgical leaders to discuss persistent challenges and unmet needs in breast-conserving surgery and explore how the Breast Cancer Locator System may support improved surgical precision, workflow efficiency, and clinical outcomes.

Program Objective

To review clinical data from the pivotal Breast Cancer Locator study and explore how patient-specific, 3D-printed technology may address unmet needs in breast-conserving surgery (BCS).

Ultrasound-guided Chest Wall Blockade for Surgeons—A Hands-on Workshop at ASBrS. This workshop is designed to equip medical professionals with advanced techniques aimed at enhancing recovery and minimizing opioid usage in breast surgery procedures. The workshop will emphasize the integration of regional blocks into comprehensive multimodal analgesia protocols, incorporating non-opioid medications, adjuvant therapies, and patient-centered approaches to optimize pain control and recovery outcomes. Attendees will delve into the intricacies of regional nerve blocks and infiltration methods, honing their skills under the guidance of expert faculty.

Faculty

Jeff Gadsden, MD

Join us for an engaging, case-based breakfast discussion exploring how Pathlight MRD is enabling disease monitoring across the breast cancer journey. From neoadjuvant response to metastatic relapse, we’ll examine how ultra-sensitive structural variant detection is changing what we know and what that means for real-world clinical decision-making.

Program Objectives Include

• Discuss the science behind Pathlight’s structural variant–based MRD and how it differs from SNV-based assays
• Review key data updates from San Antonion Breast Cancer Symposium in neoadjuvant, adjuvant, and metastatic settings
• Dive into real patient cases illustrating how MRD can help inform the breast cancer care pathway.

Presenters

• Valerie Gorman, MD, FACS
  Breast Surgical Oncologist
  Texas Breast Center and Texas Surgical Specialists
• Jason Carey, PhD
  Senior Director, Medical Science Liaison
  SAGA Diagnostics

For More Information

Katie Tesnar, katie.tesnar@sagadiagnostics.com, 202‑680‑8123